Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Amanta Healthcare Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

There is strong demand for SteriPort products, leading to an expansion in capacity from 6.6 crore to approximately 12 crore bottles per year. Key concall…

25 Aug 2026

Sejal Glass Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

The order book is strong with AED70 million (~INR175 crores) in UAE and INR50 crores in India, providing 6-9 months of execution visibility (Page 6, 7). Key…

25 Aug 2026

Monte Carlo Fashions Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

The order book was initially strong enough to support 15% to 20% growth, as indicated in the fourth quarter. Key concall takeaways from Monte Carlo Fashions's…

25 Aug 2026

RSWM Q1 FY27: Revenue ₹1,161 Cr, EBITDA margin 8% | Arthneeti

Q1 FY27

Q1 FY27 revenue grew slightly by 1.7% QoQ to ₹1,161 crores, with domestic sales increasing and exports softening due to global factors. Key concall takeaways…

25 Aug 2026

Sumeet Industries Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Product diversification and introduction of value-added yarns (currently 30%-35% of production) support growth. Key concall takeaways from Sumeet Industries…

25 Aug 2026

Gala Precision Engineering Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

New product lines, including smart fasteners and bolt products, are gradually increasing contribution (30%-35% of order book from new products). Key concall…

25 Aug 2026

Castrol India Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Volume growth is complemented by strategic pricing actions to maintain EBITDA margins of 21%-24%. Key concall takeaways from Castrol India's Q1 FY27 earnings…

25 Aug 2026

Neuland Laboratories Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

The company is investing significantly (~INR 203 crores capex in Q1 FY27) in capacity expansions and strategic growth initiatives. Key concall takeaways from…

25 Aug 2026

Sudeep Pharma Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

. Key concall takeaways from Sudeep Pharma's Q1 FY27 earnings call — and how it ranks against sector peers.

25 Aug 2026

Park Medi World Q1 FY27: Capex ₹767 Cr | Arthneeti

Q1 FY27

2,080 crores in revenue. Key concall takeaways from Park Medi World's Q1 FY27 earnings call — and how it ranks against sector peers.

25 Aug 2026

Blue Dart Expres Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Surface B2B has shown strong growth (~14%) and is contributing to overall volume increase. Key concall takeaways from Blue Dart Expres's Q1 FY27 earnings call…

25 Aug 2026

Zydus Wellness Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

EBITDA percentage expanded by 0.4% on a like-to-like basis; net profit (excluding amortization) grew 26.5% YoY in Q1 FY27. Key concall takeaways from Zydus…

25 Aug 2026

Emami Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Key concall takeaways from Emami's Q1 FY27 earnings call…

25 Aug 2026

Torrent Pharmaceuticals Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Organic India growth excluding semaglutide showed a 15-16% trajectory; top 10 base brands are growing over 20%. Key concall takeaways from Torrent Pharmaceuticals's Q1…

25 Aug 2026

ASK Automotive Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

70 crore to Rs. Key concall takeaways from ASK Automotive Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

25 Aug 2026

Shilpa Medicare Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Formulations have over 50% captive production, supporting stable growth. Key concall takeaways from Shilpa Medicare's Q1 FY27 earnings call — and how it ranks…

25 Aug 2026

Kirloskar Brothers Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

217 crores. Key concall takeaways from Kirloskar Brothers's Q1 FY27 earnings call — and how it ranks against sector peers.

25 Aug 2026

Cohance Life Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

The commercial OTIF (On-Time In-Full) rate remains near 100%, indicating strong order fulfillment performance. Key concall takeaways from Cohance Life's Q1…

25 Aug 2026

Kansai Nerolac Paints Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Moderate capacity utilization currently; capex intended to meet demand growth and improve ROCE toward 18%. Key concall takeaways from Kansai Nerolac Paints…

25 Aug 2026

Garware Hi Tech Q1 FY27 earnings call: Revenue & Margins | Arthneeti

Q1 FY27

Garware Hi-Tech Films is confident of achieving INR 2,500 crores+ revenue in the current year (FY27). Key concall takeaways from Garware Hi Tech's Q1 FY27…

25 Aug 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access